Niamh Duffy
Papers
1
Total Citations
17
H-Index
1
About
Dr Niamh Duffy is a pioneering figure in the field of advanced therapeutic medicinal products (ATMPs) and cell therapy manufacturing. Her research focuses on the critical challenge of translating novel, life-saving cell-based therapies from the lab bench to scalable, clinically-compliant production. Dr Duffy’s major contribution lies in the design and development of fully automated, robot-assisted manufacturing platforms, a concept she terms "needle to needle" production. Her most-cited work (2022, 17 citations) introduces a transformative approach to replace costly, high-risk, and limited-scale manual cell expansion processes with robotic systems that ensure consistent, high-quality, GMP-grade output. This innovation directly addresses the bottleneck of manufacturing large volumes of cells for untreatable diseases. By integrating robotics into the entire production chain, her work promises to reduce costs and risks while dramatically increasing scale, making advanced therapies more accessible. Dr Duffy’s research is not only technically rigorous but also highly translational, positioning her as a key architect of the future of cell therapy. Her achievements are paving the way for a new era in regenerative medicine, where automated manufacturing unlocks the full potential of ATMPs for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1